Dosimetric analysis of computed tomography guided three-dimensional intracavitray brachytherapy in e

来源 :2015北京首届国际近距离治疗肿瘤学术大会暨2015北京首届国际放射肿瘤学术论坛 | 被引量 : 0次 | 上传用户:zh0518
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
  Objective To study the dosimetric peculiarity of 3D intracavitary brachytherapy in the application of endometrial carcinoma by comparing with traditional 2D plans.Method 39 times of 3D intracavitary brachytherapy treatment plans of 11 patients who were diagnosis as Endometrial carcinoma were retrospectively analyzed with re-planning two-dimensional treatment plan according to traditional method, the dose volume histogram (DVH) parameters such as the target dose volume parameters V150 and D90, the 2-cc doses to organs such as bladder、 small intestine、 rectum and sigmoid and the total reference air kerma TRAK were analyzed.The differences between the two groups are compared by paired samples T test.Results For small target (V<60 cm3) , there is no statistically significant difference between 2D and 3D plans, the D90 is (551.17 ? 90.33) cGy and (574.15 ? 117.18 cGy, respectively (P=0.390).With the increase of target volume, the D90 came to be significantly different(P=0.001), high dose region V150 for 3D and 2D plans is (51.05? 21.61) cm3 and (53.41? 11.71) cm3 , respectively (P=0.482).With the target volume larger than 60 cm3 ,compare to 2D plans, the 3D plan can increase the target coverage as well as OAR dose except for small intestine(P=0.128).In addition, with different plan mode, the BMI did not affect the crisis organ dose such as rectum、 small intestine、 bladder and sigmoid, the P value is 0.239、0.198、 0.744 and 0.834,respectively.Conclusions For Endometrial carcinoma, compared with traditional two-dimensional plans, the 3D intracavitary brachytherapy treatment plans can significantly improve the target coverage and avoiding overdose of organs, clinical curative effect and side effect still needs further observation.
其他文献
Object We explored the relationship between obstructive sleep apnea (OSA) and depressive disorder.Method 88 patients suffered from OSA were divided into mild, moderate and severe according to the apne
目的 探讨普拉克索联合高压氧舱治疗帕金森病(Parkinsons disease,PD)合并睡眠行为障碍的疗效,从而为疾病的治疗提出干预措施.方法 选取符合修订Hoehn-Yahr(H&Y)分期评分≤Ⅲ期且合并睡眠障碍的帕金森病患者60例,其中20例使用普拉克索治疗;20例使用高压氧舱治疗;20例使用普拉克索联合高压氧舱治疗,疗程均为2月,进行对比治疗前后全夜多导睡眠图(PSG)监测参数、爱泼沃斯
目的 探讨药物因素在临床不明原因低氧血症诊断中的意义. 方法 病例分析.临床资料:患者女性,43岁,因"耳廓红肿、耳痛、耳鸣1 0月余,加重伴气促1月"到我院风湿免疫科住院治疗.患者既往身体健康,10个月前因感冒致耳廓红肿、耳痛、耳鸣,8个月前出现鼻梁塌陷,到昆明医科大学第一附属医院风湿免疫科诊断为"复发性多软骨炎".给予甲泼尼龙、环磷酰胺等治疗,前述症状无明显缓解.1月前出现鼻塞、喉部异物感、夜
会议
目的 通过1例特殊病例分析探讨左心功能障碍在睡眠呼吸暂停发生中的作用.方法 病例分析.临床资料:患者男性,28岁,因"夜间胸闷、憋气1月,加重5天"到我院睡眠中心门诊就诊.起病3月前曾在青海工作半年.既往体健,无慢性疾病史.家族中母亲患高血压,小姨死于扩心病.行便携式多导睡眠监测,整夜8小时监测显示:AHI指数58次/小时,平均血氧饱和度91%,最低血氧饱和度73%.其中,中枢性呼吸暂停384次(
会议
Purpose: To investigate the outcome of local dissection combined with 125I interstitialbrachytherapy in early parotid gland carcinomas at Peking University.Patients and Methods: 42 patients with parot
A new biological effective dose (BED) is proposed in this note.This new BED definition takes into account the fact that dose distribution is non-uniform for tumors in patients treatments.This new BED
Introduction——pediatric RMS 1.Incidence: 4.5-8% in pediatric tumor 2.Age : under 10 years old, for 80% 3.Sex: M/F 2.15/1 4.Type: embryonal 80.7%, alveolar 11.7%, other type 7.6%
会议
Background: To investigate the therapeutic efficacy of computed tomography (CT)-guided permanent percutaneous implantation of iodine-125(125I) for treating recurrent head and neck cancers.Methods: Thi
Objective:To evaluate the efficacy and safety of interstitial permanent low dose rate 125I seeds implantation under ultrasound guidance for local recurrent tumor ofhead and neck.Methods:64 consecutive
Introduction 125I seeds release a continuous low dose rate radiation (CLDR) used to treat patients with lung cancer;however, the effect is not as well characterized as other treatments, such as extern